Raffi Krikorian, CTO of Emerson Collective and former VP of engineering at Twitter, on why the window to put guardrails on AI is closing fast — and what that means for technology, politics and society.

ActiveLoop CEO David Buniatyan on building the data infrastructure behind generative AI, and what it will take for AI-designed molecules to translate into better medicines.

Caristo Diagnostics on an AI test that reads CT scans for inflammation around the coronary arteries — the warning sign radiologists miss in most patients at high risk of a heart attack.

Deep Origin co-founders Michael Antonov and Garegin Papoian on why they are betting on physics-based simulation alongside machine learning to make computational drug discovery actually work.